Novel orexin receptor agonist shows potential to improve wakefulness More: Eisai unveils promising phase 1b data for narcolepsy drug E2086 Source: News
read moreThe Trump administration has excluded generic drugs from a baseline 15% tariff on imports from Japan under a new trade deal between the two countries. More: Trump carves out generics from 15% tariffs in US-Japan trade deal Source: fierce
read moreBy nailing the primary endpoint in a phase 3 trial, Eli Lilly’s Bruton tyrosine kinase (BTK) inhibitor Jaypirca has come one step closer to reaching a broader group of patients with blood cancer. More: With 'compelling' effect size, Eli Lilly's
read more© 1994 - 2026 B.M. Pharmaceuticals